Ticker Details
Nkarta, Inc.
IPO Date:	July 10, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$166.82M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.53 | 3.90%
Avg Daily Range (30 D):	$0.07 | 3.14%
Avg Daily Range (90 D):	$0.06 | 2.92%

Institutional Daily Volume
Avg Daily Volume:	.75M
Avg Daily Volume (30 D):	.57M
Avg Daily Volume (90 D):	.66M

Trade Size
Avg Trade Size (Sh.):	122
Avg Trade Size (Sh.) (30 D):	110
Avg Trade Size (Sh.) (90 D):	153

Institutional Trades
Total Institutional Trades:	658
Avg Institutional Trade:	$1.72M
Avg Institutional Trade (30 D):	$.73M
Avg Institutional Trade (90 D):	$.87M
Avg Institutional Trade Volume:	.11M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.73M
Avg Closing Trade (30 D):	$.73M
Avg Closing Trade (90 D):	$.87M
Avg Closing Volume:	112.62K

News

Apr 6, 2026 @ 5:00 PM Idiopathic Membranous Nephropathy Market is Predic... Source: Delveinsight

Feb 27, 2026 @ 1:00 PM Nkarta to Participate in March Investor Conference... Source: Na

Apr 1, 2025 @ 12:01 PM Nkarta to Participate in an April Investor Confere... Source: N/A

Nov 26, 2024 @ 12:02 PM Nkarta to Participate in an Upcoming Investor Conf... Source: N/A

Sep 3, 2024 @ 8:01 PM Nkarta to Participate in Upcoming Investor Confere... Source: N/A

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-1.41	$-.37	$-1.41
Diluted EPS	$-1.41	$-.37	$-1.41
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-104.08M	$-27.41M	$-104.08M
Operating Income / Loss	$-122M	$-30.96M	$-122M
Cost of Revenue
Net Cash Flow	$11.76M	$-20.48M	$11.76M
PE Ratio